FDA clears PrecisionOS to market VR surgical planning tool


Software provides 3D reconstruction of patient’s CT scans via Oculus Quest 2

VANCOUVER, BC, November 30, 2021 / PRNewswire / – PrecisionOS® received 510 (k) clearance from the US Food and Drug Administration (FDA) to market InVisionOS ™, a patient-specific planning tool using virtual reality (VR). The patented software, which will be available in early 2022, allows surgeons to use an Oculus Quest 2 device to perform preoperative planning.

InVisionOS runs on Meta’s Oculus Quest2 laptop (CNW Group / PrecisionOS Technology)

InVisionOS is a next-generation patient-specific planning tool. Currently, surgeons view a simulated 3D image of the patient on a computer screen and then transport that mental model to the operating room. InVisionOS software automatically converts the patient’s computed tomography (CT) scan from any PACS system into a 3D reconstruction in seconds. Surgeons can then use the Oculus Quest 2 to visualize, manipulate and isolate relevant anatomical areas before performing the actual surgical procedure.

“We are focused on developing products that improve the confidence, skill and mastery of surgeons, which ultimately benefits patient outcomes,” says Danny goel, MD, CEO, PrecisionOS. “Our new InVisionOS software, which took four years to develop, allows surgeons to visualize specific patient needs and better plan surgery. “

InVisionOS is a Class II medical device cleared under the FDA 510 (k) pre-market submission program, which required the company to demonstrate the safety and efficacy of the device.

About PrecisionOS
PrecisionOS was founded in partnership with educators of clinical orthopedic surgeons and an expert group of XR (Virtual Reality, Augmented Reality and Mixed Reality) developers to create simulation training for practicing surgeons, residents and device representatives surgical. Participants using the PrecisionOS modules engage in a realistic operating environment, alone or in collaboration with other trainees all over the world, test their knowledge and desire to try other approaches, receive informative feedback and repeat the procedures until mastery is achieved. With InVisionOS, a patient-specific planning tool, the company expands into providing next-generation products for preoperative surgery and simulation training and education.

PrecisionOS is based at Vancouver, BC, with collaborative affiliations with over 40 leading medical institutions in the United States and Canada. The company’s software is used in more than 40 countries and 600 cities around the world. For more information, please visit www.precisionostech.com.

Media contact:
Elaine murphy; 818,613,1951; [email protected]



View original content to download multimedia:https://www.prnewswire.com/news-releases/fda-authorizes-precisionos-to-market-vr-surgical-planning-tool-301433571.html

SOURCE PrecisionOS technology


Comments are closed.